178 related articles for article (PubMed ID: 27040795)
1. Vilazodone does not inhibit sexual behavior in male rats in contrast to paroxetine: A role for 5-HT1A receptors?
Oosting RS; Chan JSW; Olivier B; Banerjee P
Neuropharmacology; 2016 Aug; 107():271-277. PubMed ID: 27040795
[TBL] [Abstract][Full Text] [Related]
2. Differential effects of vilazodone versus citalopram and paroxetine on sexual behaviors and serotonin transporter and receptors in male rats.
Oosting RS; Chan JS; Olivier B; Banerjee P; Choi YK; Tarazi F
Psychopharmacology (Berl); 2016 Mar; 233(6):1025-34. PubMed ID: 26758283
[TBL] [Abstract][Full Text] [Related]
3. Mechanism of action of the bimodal antidepressant vilazodone: evidence for serotonin1A-receptor-mediated auto-augmentation of extracellular serotonin output.
van Amsterdam C; Seyfried CA
Psychopharmacology (Berl); 2014 Jun; 231(12):2547-58. PubMed ID: 24419272
[TBL] [Abstract][Full Text] [Related]
4. The Preclinical and Clinical Effects of Vilazodone for the Treatment of Major Depressive Disorder.
Sahli ZT; Banerjee P; Tarazi FI
Expert Opin Drug Discov; 2016; 11(5):515-23. PubMed ID: 26971593
[TBL] [Abstract][Full Text] [Related]
5. Vilazodone: a 5-HT1A receptor agonist/serotonin transporter inhibitor for the treatment of affective disorders.
Dawson LA; Watson JM
CNS Neurosci Ther; 2009; 15(2):107-17. PubMed ID: 19499624
[TBL] [Abstract][Full Text] [Related]
6. Neurochemical evaluation of the novel 5-HT1A receptor partial agonist/serotonin reuptake inhibitor, vilazodone.
Hughes ZA; Starr KR; Langmead CJ; Hill M; Bartoszyk GD; Hagan JJ; Middlemiss DN; Dawson LA
Eur J Pharmacol; 2005 Mar; 510(1-2):49-57. PubMed ID: 15740724
[TBL] [Abstract][Full Text] [Related]
7. Effects of chronic selective serotonin reuptake inhibitors on 8-OH-DPAT-induced facilitation of ejaculation in rats: comparison of fluvoxamine and paroxetine.
de Jong TR; Pattij T; Veening JG; Waldinger MD; Cools AR; Olivier B
Psychopharmacology (Berl); 2005 May; 179(2):509-15. PubMed ID: 15719219
[TBL] [Abstract][Full Text] [Related]
8. Neurochemical and behavioural effects of hypidone hydrochloride (YL-0919): a novel combined selective 5-HT reuptake inhibitor and partial 5-HT
Zhang LM; Wang XY; Zhao N; Wang YL; Hu XX; Ran YH; Liu YQ; Zhang YZ; Yang RF; Li YF
Br J Pharmacol; 2017 May; 174(9):769-780. PubMed ID: 27882537
[TBL] [Abstract][Full Text] [Related]
9. Other Antidepressants.
Schwasinger-Schmidt TE; Macaluso M
Handb Exp Pharmacol; 2019; 250():325-355. PubMed ID: 30194544
[TBL] [Abstract][Full Text] [Related]
10. Tramadol: Effects on sexual behavior in male rats are mainly caused by its 5-HT reuptake blocking effects.
Olivier JD; Esquivel Franco DC; Oosting R; Waldinger M; Sarnyai Z; Olivier B
Neuropharmacology; 2017 Apr; 116():50-58. PubMed ID: 27890601
[TBL] [Abstract][Full Text] [Related]
11. Long-term administration of the antidepressant vilazodone modulates rat brain monoaminergic systems.
El Mansari M; Crnic A; Oosterhof C; Blier P
Neuropharmacology; 2015 Dec; 99():696-704. PubMed ID: 26362359
[TBL] [Abstract][Full Text] [Related]
12. Effects of chronic paroxetine pretreatment on (+/-)-8-hydroxy-2-(di-n-propyl-amino)tetralin induced c-fos expression following sexual behavior.
de Jong TR; Pattij T; Veening JG; Dederen PJ; Waldinger MD; Cools AR; Olivier B
Neuroscience; 2005; 134(4):1351-61. PubMed ID: 16019152
[TBL] [Abstract][Full Text] [Related]
13. Revealing vilazodone's binding mechanism underlying its partial agonism to the 5-HT
Zheng G; Xue W; Yang F; Zhang Y; Chen Y; Yao X; Zhu F
Phys Chem Chem Phys; 2017 Nov; 19(42):28885-28896. PubMed ID: 29057413
[TBL] [Abstract][Full Text] [Related]
14. Electrophysiological evidence for rapid 5-HT₁A autoreceptor inhibition by vilazodone, a 5-HT₁A receptor partial agonist and 5-HT reuptake inhibitor.
Ashby CR; Kehne JH; Bartoszyk GD; Renda MJ; Athanasiou M; Pierz KA; Seyfried CA
Eur J Pharmacol; 2013 Aug; 714(1-3):359-65. PubMed ID: 23872377
[TBL] [Abstract][Full Text] [Related]
15. Serotonin 1A receptors and sexual behavior in a genetic model of depression.
Schijven D; Sousa VC; Roelofs J; Olivier B; Olivier JD
Pharmacol Biochem Behav; 2014 Jun; 121():82-7. PubMed ID: 24345571
[TBL] [Abstract][Full Text] [Related]
16. Vilazodone, a Selective Serotonin Reuptake Inhibitor with Diminished Impact on Methylphenidate-Induced Gene Regulation in the Striatum: Role of 5-HT1A Receptor.
Hrabak M; Moon C; Bolaños-Guzmán CA; Steiner H
Mol Neurobiol; 2024 Apr; 61(4):1907-1919. PubMed ID: 37807008
[TBL] [Abstract][Full Text] [Related]
17. A new female rat animal model for hypoactive sexual desire disorder; behavioral and pharmacological evidence.
Snoeren EM; Chan JS; de Jong TR; Waldinger MD; Olivier B; Oosting RS
J Sex Med; 2011 Jan; 8(1):44-56. PubMed ID: 20807327
[TBL] [Abstract][Full Text] [Related]
18. Vilazodone hydrochloride, a combined SSRI and 5-HT1A receptor agonist for major depressive disorder.
Guay DR
Consult Pharm; 2012 Dec; 27(12):857-67. PubMed ID: 23229074
[TBL] [Abstract][Full Text] [Related]
19. Activating SRC/MAPK signaling via 5-HT1A receptor contributes to the effect of vilazodone on improving thrombocytopenia.
Zhou L; Ni C; Liao R; Tang X; Yi T; Ran M; Huang M; Liao R; Zhou X; Qin D; Wang L; Huang F; Xie X; Wan Y; Luo J; Wang Y; Wu J
Elife; 2024 Apr; 13():. PubMed ID: 38573820
[TBL] [Abstract][Full Text] [Related]
20. SB-649915-B, a novel 5-HT1A/B autoreceptor antagonist and serotonin reuptake inhibitor, is anxiolytic and displays fast onset activity in the rat high light social interaction test.
Starr KR; Price GW; Watson JM; Atkinson PJ; Arban R; Melotto S; Dawson LA; Hagan JJ; Upton N; Duxon MS
Neuropsychopharmacology; 2007 Oct; 32(10):2163-72. PubMed ID: 17356576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
